Jenscare Scientific Co., Ltd. (9877.HK)

HKD 5.61

(-3.77%)

Market Cap (In HKD)

2.34 Billion

Revenue (In HKD)

-

Net Income (In HKD)

-371.73 Million

Avg. Volume

237.63 Thousand

Currency
HKD
Country
Open
-
Prev. Close
-
Day Range
-
Year Range
1.4-22.3
PE
-12.2
EPS
-0.46
Beta Value
0.654
ISIN
CNE100005KC9
CUSIP
-
CIK
-
Shares
417167013.0
Earnings Annoncement
-

Company Profile

Sector
Industry
CEO
Mr. Shiwen Lv
Employee Count
-
Website
https://www.jenscare.com
Ipo Date
2022-10-10
Details
Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of invasive interventional therapies for structural heart diseases in the People's Republic of China. The company offers LuX-Valve, a transcatheter tricuspid valve replacement (TTVR) product candidate for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. Its products have applications in the treatment of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, and heart failure. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China.

More Stocks